Literature DB >> 8635853

Tumour development, histology and grade of breast cancers: prognosis and progression.

L Tabar1, G Fagerberg, H H Chen, S W Duffy, A Gad.   

Abstract

Using 1,973 breast tumours from women aged 40-69 participating in the Swedish two-county trial of mammographic screening for breast cancer, we examined the effect of histological type on prognosis and sojourn time (the duration of the preclinical screen-detectable phase) by age. The hypothesis of dedifferentiation, according to which a cancer of mixed malignancy grade drifts towards grade 3 as the more poorly differentiated part of the tumour grows faster than the well-differentiated part, was also assessed. Ductal carcinoma in situ, invasive ductal carcinoma of grade 1, mucinous carcinoma and tubular carcinoma were all associated with good survival. Ductal carcinoma of grade 3 was associated with poor survival. Ductal carcinoma of grade 2, lobular and medullary carcinoma were associated with intermediate survival. These patterns were much the same in women aged 40-49 as in women aged 50-69. In women aged 40-49, sojourn time was estimated at about 2 years regardless of histological type. For women aged 50-69, there was a marked association of sojourn time with histological type, the shortest sojourn time being observed for lobular (2 years) and medullary (1.2 years) carcinoma, and the longest for ductal carcinoma grade 1 (7.7 years) and tubular carcinoma (7.1 years). There was strong evidence of a potential to dedifferentiation. A mover-stayer mixture of Markov chain models estimated that, in women aged 40-54, 91% of ductal tumours have the potential to dedifferentiate and, in women aged 55-69, 38% of ductal tumours have such a potential.

Entities:  

Mesh:

Year:  1996        PMID: 8635853     DOI: 10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden.

Authors:  H H Chen; E Thurfjell; S W Duffy; L Tabar
Journal:  J Epidemiol Community Health       Date:  1998-05       Impact factor: 3.710

2.  Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.

Authors:  Diana L Miglioretti; Jane Lange; Jeroen J van den Broek; Christoph I Lee; Nicolien T van Ravesteyn; Dominique Ritley; Karla Kerlikowske; Joshua J Fenton; Joy Melnikow; Harry J de Koning; Rebecca A Hubbard
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

3.  Selection, establishment and characterization of cell lines derived from a chemically-induced rat mammary heterogeneous tumor, by flow cytometry, transmission electron microscopy, and immunohistochemistry.

Authors:  L Teodori; F Tagliaferri; F Stipa; M G Valente; D Coletti; A Manganelli; M Guglielmi; L S D'Angelo; H Schäfer; W Göhde
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

4.  Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

5.  Computerized three-class classification of MRI-based prognostic markers for breast cancer.

Authors:  Neha Bhooshan; Maryellen Giger; Darrin Edwards; Yading Yuan; Sanaz Jansen; Hui Li; Li Lan; Husain Sattar; Gillian Newstead
Journal:  Phys Med Biol       Date:  2011-08-22       Impact factor: 3.609

6.  Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta).

Authors:  Amanda P Beck; Amos Brooks; Caroline J Zeiss
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

Review 7.  Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

Authors:  O W Petersen; L Rønnov-Jessen; V M Weaver; M J Bissell
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

8.  Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.

Authors:  Grethe Albrektsen; Ivar Heuch; Steinar Ø Thoresen
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

9.  Genomic heterogeneity of breast tumor pathogenesis.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Craig D Shriver; Darrell L Ellsworth
Journal:  Clin Med Oncol       Date:  2009-07-29

10.  Measures of benefit for breast screening from the pathology database for Scotland, 1991-2001.

Authors:  T J Anderson; C Davis; F E Alexander; H M Dobson
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.